Temporary Stimulation Switch-off Successfully Applied in a Dystonic Camptocormia Patient
Pingchen Zhang,Dianyou Li,Jun Liu,Shengdi Chen,Yuyan Tan,Haiyan Zhou
DOI: https://doi.org/10.1002/mdc3.13397
2022-01-01
Movement Disorders Clinical Practice
Abstract:Camptocormia is a disabling postural abnormality characterized by marked forward flexion of the thoracolumbar spine, which escalates during standing and walking but relieves in the recumbent position.1 Although there is no established consensus for treatment of camptocormia, case series suggested that deep brain stimulation (DBS) of the globus pallidus interna (GPi) was effective in dystonic camptocormia.2, 3 Here we present one patient with severe camptocormia as part of generalized dystonia, treated with GPi-DBS. There had been a significant improvement after stimulation, but the effect displayed as a repetitive “improvement-plateau-rebound” pattern, which finally resolved by overnight stimulation switch-off strategy. A 63-year-old female patient experienced the initial symptom of a truncal flexion during long distance walking at age 57, followed by sensation of involuntary abdominal contraction and intermittent trunk tremor 1 year later. After 6-year progression, the trunk flexion severely limited her daily activities. Her family history was negative. Physical examination showed marked camptocormia with her spine bent above 90°, slight torticollis and bilateral shoulder intra-rotation (Video 1, Section 1), without any feature of parkinsonism. Laboratory tests including creatine phosphokinase, lactate, serum ammonia and ceruloplasmin were normal. Both brain and spinal cord MRI scan were unremarkable. Electromyography recorded dystonic bursts in bilateral rectus abdominis muscles and no neuropathic or myopathic changes were found in paraspinal muscles. Neuropsychological assessment revealed no cognitive impairment. Neither inconsistent neurological findings nor unusual disease course was suggestive of a psychogenic movement disorder. Idiopathic late adulthood-onset generalized dystonia with camptocormia was diagnosed. Treatment trials with levodopa (300 mg/day), baclofen (30 mg/day) and clonazepam (3 mg/day) showed no beneficial effects. Botulinumtoxin A injection to the rectus abdominis muscles (200 units) only showed transient mild effect. GPi-DBS was consequently taken into consideration. Total Burke Fahn and Marsden Dystonia Rating Scale (BFMDRS) scores were 39 preoperatively (Table 1). The surgery procedure was performed as described in our previous published study.4 Quadripolar electrodes (L302, PINS, Beijing) were implanted into bilateral GPi (Fig. 1), connected to unchargeable pulse generator (G101A, PINS, Beijing). Postoperative programming of the neurostimulator was done 4 days after surgery. Each of the four contacts was reviewed for both hemispheres (case served as anode; constant voltage/90 μs/135 Hz). Acute clinical improvement and voltage-limiting side effects were assessed. For chronic stimulation, contacts two in both hemispheres were chosen for monopolar stimulation. Initial programming parameters were: 2.7 V/110 μs/135 Hz in the left side and 2.75 V/110 μs/135 Hz in the right side (All parameter adjustments were detailed in Table S1). At 1-month follow up, remarkable improvement was recorded, especially for camptocormia. However, camptocormia, trunk tremor and cervical dystonia rebounded at 6-month. Adding contacts three in both sides was found to alleviate symptoms quickly. Total BFMDRS scores decreased to 14 and trunk subitem improved from 12 to 4 (Table 1, Video 1, Section 2). Unfortunately, 2 months later the symptoms reoccurred, but were improved again by increasing pulse width to 130 μs at 10-month follow up. This effect remained stable for 2 months and the rebound came again (Video 1, Section 3). This progressive loss of DBS benefits indicated the existence of tolerance. Thus stimulation switch-off overnight was tried at 15-month follow up. Symptoms got worse after overnight cessation (0–8 am) (Video 1, Section 4). But after switching on the previous parameters, the symptoms alleviated in 1 hour (Video 1, Section 5). Since then, stimulation switch-off during sleep (0–5 am) was applied and the patient continued to be in a stable condition for 18 months. The waning effect never came back again. Dystonic camptocormia treated with GPi-DBS has been scarcely reported2, 3 and this is the first report on overnight stimulation switch-off to successfully resolve tolerance in a dystonic camptocormia patient. The repetitive “improvement-plateau-rebound” pattern in this case was similar to the habituation phenomenon in essential tremor (ET) DBS treatment. Habituation was described as substantial loss of acute benefit from reprogramming after 10 weeks.4, 5 This case showed a waning effect about 2 months later after each programming. Although habituation of neurons or circuits is a topic of debate, it might be attributed to an adaptation of biological response of the stimulated neuronal network. There are several strategies for minimizing or preventing habituation: using DBS only when needed,6 switching DBS off at night,7 or switching between two equivalent but slightly different stimulation settings,8 etc. In this case, overnight stimulation switch-off resulted in an enduring effect. In addition, the maximal effects of GPi-DBS may take up several weeks to months to occur empirically. But the dystonic symptoms of our patient responded quickly to stimulation initiation and reprograming. This situation could be explained by that pathologically enhanced low frequency activity in patients with phasic dystonia can be suppressed immediately by high frequency stimulation whereas sustained tonic activity has a delayed response.9 In conclusion, the practical approach of temporary stimulation switch-off could be considered as a rescue therapy among the refractory habituation in GPi-DBS. We highlighted the growing demand for more rigorous investigations of the underlying mechanism in GPi-DBS to elucidate the pathophysiology of dystonia. The authors thank our patient for her generous permission for this case study. (1) Clinical Follow-up of the patient: A. Conception, B. Organization, C. Execution; (2) Manuscript Preparation: A. Writing of the first draft, B. Review and Critique; (3) Final approval. PZ: 1A-C, 2A-B, 3 DL:1B-C, 2B, 3 JL: 1B-C, 2B, 3 SC: 1B-C, 2B, 3 YT: 1A-C, 2A-B, 3 HZ: 1A-C, 2A-B, 3 The authors confirm that the approval of an institutional review board was not required for this work. We confirm that we have read the Journal's position on issues involved in ethical publication and affirm that this work is consistent with those guidelines.The patient gave her informed consent prior the inclusion in the study and written informed consent was obtained for videotaping and to use the videos for scientific purposes. This research received the following governmental funding: National Natural Science Foundation of China (No. 81971183). The authors declare that there are no conflicts of interest relevant to this work. The authors declare that there are no additional disclosures to report. Appendix S1 Transcription for Video 1. Table S1 Summary of stimulation setting during the follow-up. Figure S1 The video cover. Please note: The publisher is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.